Combined use of oral and topical forms of phlebotonics after endovasal laser coagulation
https://doi.org/10.21518/akh2024-010
Abstract
Introduction. The combination of endovasal laser coagulation and miniphlebectomy is actively used in the treatment of Chronic venous diseases, however, the question of improving the management of such patients in the postoperative period remains actual.
Aim. To evaluate the effectiveness of the combined use of oral and topical forms of phlebotonics after endovasal laser coagulation.
Materials and methods. The study was conducted in 60 patients after surgery divided into 2 comparable (n = 30). The group 1 was treated with MPFF 1000 mg (Detralex) once a day during the perioperative period (10 days before surgery and up to 2 months after) and additionally topical Detragel daily 3 times a day for 10 days after the intervention. The group 2 used heparin topical form for 10 days after surgery. Control was carried out on the 1st day, 10th day after surgery, as well as after 3 and 6 months.
Results. In group 1, there was a statistically more significant decrease in the level of pain on days 1 and 10 after surgery (p ≤ 0.05), while the frequency of hyperpigmentation at months 3 and 6 after surgery was also less presented.
Conclusions. The combination of endovasal laser coagulation and miniphlebectomy while taking MPFF and a gel based on heparin, escin and essential phospholipids is accompanied by less severe pain and the level of hyperpigmentation in the postoperative period.
About the Authors
Yu. M. Chubirko
Voronezh State Medical University named after. N.N. Burdenko; Clinic “Doctor Ch”
Russian Federation
Russian Federation
Yuriy M. Chubirko - Cand. Sci. (Med.), Associate Professor, Vascular Surgeon, Angiologist, VSMU named after N.N. Burdenko; Phlebologist, Clinic “Doctor Ch”.
10, Studencheskaya St., Voronezh, 394036; 2в, Ippodromnaya St., Voronezh, 394068
I. O. Kasyanov
Clinic “Doctor Ch”
Russian Federation
Russian Federation
Ilya O. Kasyanov - Vascular Surgeon, Phlebologist.
2в, Ippodromnaya St., Voronezh, 394068
References
1. Апханова ТВ, Булатов ВЛ, Вахратьян ПЕ, Волков АМ, Волков АС, Гаврилов ЕК и др. Варикозное расширение вен нижних конечностей. М.; 2021. Режим доступа: https://cr.minzdrav.gov.ru/schema/680_1#doc_b.
2. Criqui M, Jamosmos M, Fronek A, Denenberg J, Langer R, Bergan J, Golomb B. Chronic Venous Disease in an Ethnically Diverse Population: The San Diego Population Study. Am J Epidemiol. 2003;158(5):448–456. https://doi.org/10.1093/aje/kwg166.
3. Rabe E, Guex J, Puskas A, Scuderi A, Fernandez Quesada F. Epidemiology of chronic venous disorders in geographically diverse populations: results from the Vein Consult Program. Int Angiol. 2012;31(2):105–115. Available at: https://pubmed.ncbi.nlm.nih.gov/22466974.
4. Savel’ev VS, Kirienko AI, Zolotukhin IA, Seliverstov EI. Prospective observational study SPECTRUM: the registry of patients with chronic venous diseases. Flebologiya. 2012;6(1):4–9. (In Russ.) Available at: https://www.mediasphera.ru/issues/flebologiya/2012/1/031997-6976201211.
5. Mazaishvili KV, Chen VI. Chronic venous diseases of lower limbs in Petropavlovsk-Kamchatksky. Flebologiya. 2008;2(4):52–54. (In Russ.) Available at: https://elibrary.ru/ndyphr.
6. Kirienko AI, Bogachev VYu, Gavrilov SG, Zolotukhin IA, Golovanova OV, Zhuravleva OV BA. Chronic diseases of lower extremity veins in industrial workers of Moscow (results of the epidemiological survey). Angiology and Vascular Surgery. 2004;10(1):77–85. (In Russ.) Available at: https://www.angiolsurgery.org/magazine/2004/1/11.htm.
7. Bogachev VYu, Boldin BV, Turkin PYu. Modern therapy of chronic venous disorders of the lower limbs: transdermal phlebotropic medications in focus. RMJ. 2018;6(II):61–65. (In Russ.) Available at: https://www.rmj.ru/articles/angiologiya/Sovremennaya_terapiya_hronicheskih_zabolevaniy_ven_nighnih_konechnostey_v_fokuse_transdermalynye_flebotropnye_preparaty/?ysclid=lu0tyeiq9z161849704.
8. Nicolaides A, Kakkos S, Baekgaard N, Comerota A, de Maeseneer M, Eklof B. Management of chronic venous disorders of the lower limbs. Guidelines According to Scientific Evidence. Part II. Int Angiol. 2020;39(3):175–240. https://doi.org/10.23736/S0392-9590.20.04388-6.
9. Nicolaides A, Kakkos S, Eklof B, Perrin M, Nelzen O, Neglen P. Management of chronic venous disorders of the lower limbs – guidelines according to scientific evidence. Int Angiol. 2014;33(2):87–208. Available at: https://pubmed.ncbi.nlm.nih.gov/24780922.
10. Gloviczki P, Dalsing MC, Eklof B, Gloviczki ML, Lurie F, Wakefield TW (ed.). Handbook of venous and lymphatic disorders: guidelines of the American Venous Forum. 4th ed. CRC Press; 2017. 866 p.
11. Wittens C, Davies AH, Bækgaard N, Broholm R, Cavezzi A, Chastanet S et al. Management of Chronic Venous Disease. Eur J Vasc Endovasc Surg. 2015;49(6):678–737. https://doi.org/10.1016/j.ejvs.2015.02.007.
12. Nesbitt C, Bedenis R, Bhattacharya V, Stansby G. Endovenous ablation (radiofrequency and laser) and foam sclerotherapy versus open surgery for great saphenous vein varices. Cochrane Database Syst Rev. 2014;7:CD005624. https://doi.org/10.1002/14651858.CD005624.pub3.
13. Paravastu SC, Horne M, Dodd PD. Endovenous ablation therapy (laser or radiofrequency) or foam sclerotherapy versus conventional surgical repair for short saphenous varicose veins. Cochrane Database Syst Rev. 2016;11(11):CD010878. https://doi.org/10.1002/14651858.CD010878.pub2.
14. Navarro L, Min RJ, Boné C. Endovenous laser: a new minimally invasive method of treatment for varicose veins – preliminary observations using an 810 nm diode laser. Dermatol Surg. 2001;27(2):117–122. https://doi.org/10.1046/j.1524-4725.2001.00134.x.
15. Vuylsteke ME, Klitfod L, Mansilha A. Endovenous ablation. Int Angiol. 2019;38(1):22–38. https://doi.org/10.23736/S0392-9590.18.04047-6.
16. Lobastov KV, Bondarchuk DV, Borsuk DA, Bredikhin RA, Bukina OV. Diagnosis and treatment of chronic venous obstruction: consensus statement of the russian experts (part 2). Surgeon. 2020;(7-8):22–55. (In Russ.) Available at: https://phlebology-sro.ru/upload/iblock/e01/venoznaya-obstruktsiya.-chast-2.pdf.
17. Vuylsteke M, De Bo T, Dompe G, Di Crisci D, Abbad C, Mordon S. Endovenous laser treatment: is there a clinical difference between using a 1500 nm and a 980 nm diode laser? A multicenter randomised clinical trial. Int Angiol. 2011;30(4):327–334. Available at: https://pubmed.ncbi.nlm.nih.gov/21747351.
18. Proebstle TM, Moehler T, GÜL D, Herdemann S. Endovenous treatment of the great saphenous vein using a 1,320 nm Nd:YAG laser causes fewer side effects than using a 940 nm diode laser. Dermatol Surg. 2005;31(12):1678–1684. https://doi.org/10.2310/6350.2005.31308.
19. Prince EA, Soares GM, Silva M, Taner A, Ahn S, Dubel GJ, Jay BS. Impact of laser fiber design on outcome of endovenous ablation of lowerextremity varicose veins: results from a single practice. Cardiovasc Interv Radiol. 2011;34(3):536–541. https://doi.org/10.1007/s00270010-9922-y.
20. Schwarz T, von Hodenberg E, Furtwängler C, Rastan A, Zeller T, Neumann FJ. Endovenous laser ablation of varicose veins with the 1470-nm diode laser. J Vasc Surg Elsevier Inc. 2010;51(6):1474–1478. https://doi.org/10.1016/j.jvs.2010.01.027.
21. Doganci S, Demirkilic U. Comparison of 980 nm laser and bare-tip fibre with 1470 nm laser and radial fibre in the treatment of great saphenous vein varicosities: a prospective randomised clinical trial. Eur J Vasc Endovasc Surg. 2010;40(2):254–259. https://doi.org/10.1016/j.ejvs.2010.04.006.
22. Hirokawa M, Ogawa T, Sugawara H, Shokoku S, Sato S. Comparisonof 1470 nm LaserandRadial 2ringFiberwith 980 mm: AMulticenter, Prospective, Randomized, Non-Blind Study. Ann Vasc Dis. 2015;8(4):282–289. https://doi.org/10.3400/avd.oa.15-00084.
Review
For citations:
Chubirko Yu.M., Kasyanov I.O. Combined use of oral and topical forms of phlebotonics after endovasal laser coagulation. Ambulatornaya khirurgiya = Ambulatory Surgery (Russia). 2024;21(1):42-47. (In Russ.) https://doi.org/10.21518/akh2024-010
Views:
993
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International.
Email this article 